We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+22.5%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$664M
AUM Growth
-$183M
(-22%)
Cap. Flow
-$289M
Cap. Flow
% of AUM
-43.52%
Top 10 Holdings %
Top 10 Hldgs %
55.23%
Holding
79
New
18
Increased
15
Reduced
15
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ally Financial
ALLY
|
+$22.3M |
| 2 |
Crocs
CROX
|
+$15.1M |
| 3 |
Vertiv
VRT
|
+$14.1M |
| 4 |
MOMO
Hello Group
MOMO
|
+$12.1M |
| 5 |
Fastenal
FAST
|
+$9.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$30.6M |
| 2 |
Aramark
ARMK
|
+$26.4M |
| 3 |
Alibaba
BABA
|
+$22.5M |
| 4 |
argenx
ARGX
|
+$21M |
| 5 |
Motorola Solutions
MSI
|
+$20.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.87% |
| 2 | Consumer Discretionary | 13.24% |
| 3 | Technology | 8.87% |
| 4 | Industrials | 8.8% |
| 5 | Communication Services | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
26
DELISTED
Molecular Templates, Inc.
MTEM
| $9.73M | 1.47% |
46,367
+10,263
| +28% | +$1.48M |
|
27
Salesforce
CRM
$156B
| $9.38M | 1.41% |
57,691
-37,338
| -39% | -$5.85M |
|
28
Ingersoll Rand
IR
$34.7B
| $8M | 1.2% |
+218,000
| New | +$7.15M |
|
|
TVRD
29
Tvardi Therapeutics
TVRD
$19M
| $7.6M | 1.14% |
13,099
+5,271
| +67% | +$3.7M |
|
|
GTYH
30
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $7.06M | 1.06% |
1,198,212
-1,788
| -0.1% | -$9.66K |
|
31
Great Elm Group
GEG
$67.4M
| $4.23M | 0.64% |
1,267,030
| – | – |
|
32
Veeva Systems
VEEV
$34.4B
| $4.22M | 0.64% |
+30,000
| New | +$4.41M |
|
|
HUYA
33
Huya Inc
HUYA
$586M
| $4.12M | 0.62% |
229,484
-416,254
| -64% | -$8.8M |
|
|
TMQ
34
Trilogy Metals
TMQ
$594M
| $4.08M | 0.61% |
1,569,446
+120,000
| +8% | +$232K |
|
|
PVG
35
DELISTED
PRETIUM RESOURCES INC.
PVG
| $3.85M | 0.58% |
345,889
+45,889
| +15% | +$488K |
|
36
Lattice Semiconductor
LSCC
$19.6B
| $3M | 0.45% |
156,791
-170,486
| -52% | -$3.27M |
|
37
Beyond Air
XAIR
$4.45M
| $2.81M | 0.42% |
1,344
+342
| +34% | +$593K |
|
38
Purple Innovation
PRPL
$42.4M
| $2.78M | 0.42% |
+12,752
| New | +$2.46M |
|
39
PUT
Iovance Biotherapeutics
IOVA
$1.95B
| $2.77M | 0.42% |
+100,000
| New | +$2.27M |
|
|
ATNX
40
CALL
DELISTED
Athenex, Inc. Common Stock
ATNX
| $2.29M | 0.35% |
+7,500
| New | +$1.98M |
|
41
SCYNEXIS
SCYX
$53.6M
| $2.09M | 0.31% |
+28,681
| New | +$2.37M |
|
42
CALL
Aurinia Pharmaceuticals
AUPH
$1.92B
| $2.03M | 0.31% |
+100,000
| New | +$921K |
|
|
ARQL
43
CALL
DELISTED
Arqule Inc
ARQL
| $2M | 0.3% |
100,000
| – | – |
|
|
CARM
44
DELISTED
Carisma Therapeutics
CARM
| $1.92M | 0.29% |
92,281
-215,485
| -70% | -$4.95M |
|
|
SONG
45
DELISTED
Akazoo SA
SONG
| $1.7M | 0.26% |
321,600
| – | – |
|
|
GNCA
46
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.52M | 0.23% |
733,050
+46,828
| +7% | +$111K |
|
47
Meta Platforms (Facebook)
META
$1.5T
| $1.27M | 0.19% |
6,190
-83,106
| -93% | -$16.1M |
|
48
Exicure
XCUR
$9.82M
| $1M | 0.15% |
+2,333
| New | +$955K |
|
|
49
Aurinia Pharmaceuticals
AUPH
$1.92B
| $885K | 0.13% |
+43,669
| New | +$402K |
|
50
Regeneron Pharmaceuticals
REGN
$78.3B
| $714K | 0.11% |
1,901
-60,564
| -97% | -$20.4M |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Kingdon Capital Management held 79 positions worth $664M, down 22% from $847M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Kingdon Capital Management withdrew a net $289M in Q4 2019, closing 24 positions and reducing 15 holdings. Its most notable exit was Marathon Petroleum, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Kingdon Capital Management opened a new position in Ally Financial worth $21.8M.
- Kingdon Capital Management's largest Q4 2019 buy was Ally Financial: 714,040 shares worth $21.8M.
- Kingdon Capital Management added most to Aerie Pharmaceuticals in Q4 2019, an estimated $8.58M increase.
- Kingdon Capital Management's biggest Q4 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $20.4M.
- Kingdon Capital Management fully exited Marathon Petroleum in Q4 2019, selling an estimated $30.6M.
- Kingdon Capital Management's ten largest holdings make up 55% of its $664M portfolio in Q4 2019.
- Kingdon Capital Management opened 18 new positions and closed 24 in Q4 2019.
- Kingdon Capital Management's portfolio value fell 22% quarter-over-quarter to $664M.
Based on Kingdon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.